Skip to content
Baltimore News Journal – Lifestyle
Author:
Belite Bio, Inc
Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease
April 21, 2026
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
March 31, 2026
←
Previous Page
1
2